Atlas Trials

Tyrosine Kinase Inhibitor

18 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Tyrosine Kinase Inhibitor

RecordFirmDate
Bevacizumab Combined With Double Doses of Icotinib in Advanced NSCLC Patients With EGFR L858R Mutation (NCT05263947)Tianjin Medical University Cancer Institute and Hospital2022-01-30
Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian Cancer (NCT04807166)Wenjun Cheng2021-08-24
The Safety and Efficacy of Transarterial Chemoembolization (TACE) + Lenvatinib + Programmed Cell Death Protein 1 (PD-1) Antibody of Advanced Unresectable Hepatocellular Carcinoma (NCT04997850)Xinrui Zhu，MD2020-10-01
Oncotool for Cancer Medications (NCT03952312)Northwestern University2020-01-15
Tyrosine Kinase Inhibitor Withdrawal Syndrome in CML Patients: Observatory Trial Studying the Biological Factors. (NCT03996096)University Hospital, Caen2019-04-23
Effect of Prophylactic TKI Therapy Post-transplants on Ph+ ALL Undergoing Allo-HSCT With MRD Positive Pre-transplants (NCT03624530)Nanfang Hospital, Southern Medical University2018-08-01
ProSpecTive sAmpling in dRiver muTation Pulmonary Oncology Patients on Tyrosine Kinase Inhibitors (START-TKI) (NCT05221372)Erasmus Medical Center2017-02-02
Effect of Pre-Transplant Tyrosine Kinase Inhibitors in Hepatocellular Carcinoma Patients With Liver Transplantation (NCT07418138)Hu Liangshuo2015-01-01

Track Tyrosine Kinase Inhibitor automatically

Every clearance here is in the API, with alerts when new ones post.